Cardioprotective phosphonates and malonates

   
   

The present invention provides for pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates) and to pyridoxine malonate analogues, such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridylmethyl)malonates), pharmaceutical compositions, and methods for treatment of cardiovascular and related diseases, and diabetes mellitus and related diseases.

La présente invention prévoit des analogues de phosphonate de pyridoxine comme, par exemple, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, et (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates) et aux analogues de malonate de pyridoxine, comme, par exemple, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridylmethyl)malonates), les compositions pharmaceutiques, et les méthodes pour le traitement des maladies cardiovasculaires et relatives, et du mellitus de diabète et des maladies relatives.

 
Web www.patentalert.com

< Aryl N-cyanoguanidines and methods related thereto

< Pyridine and pyrimidine derivatives

> Compounds, their preparation and use

> Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them

~ 00167